Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.10.0.1
Stockholders' Equity
9 Months Ended
Sep. 30, 2018
Equity [Abstract]  
Stockholders' Equity

10. Stockholders’ Equity

 

The Company has 45,000,000 shares of its $0.0001 par value common stock authorized at both September 30, 2018 and December 31, 2017. The Company had 3,706,563 and 3,045,809 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively.

 

The Company has 5,000,000 shares of its no par value preferred stock authorized at both September 30, 2018 and December 31, 2017. The Company had 62,876 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively. Holders of the preferred shares are entitled to receive cumulative dividends out of legally available funds at the rate of 9% per year for a term of seven years, payable quarterly on the last day of March, June, September and December in each year in cash or registered common stock at the election of the Company. Shares of common stock issued as dividends are issued at a 10% discount to the five-day volume weighted average price per share of common stock prior to payable date. The preferred shares are non-voting, have a liquidation preference of $13.50 per share and contain a required redemption at $13.50 plus any accrued but unpaid dividends upon maturity in 2023.

 

Options and Warrants

 

The Company’s shareholders have approved the Chanticleer Holdings, Inc. 2014 Stock Incentive Plan (the “2014 Plan”), authorizing the issuance of options, stock appreciation rights, restricted stock awards and units, performance shares and units, phantom stock and other stock-based and dividend equivalent awards. Pursuant to the approved 2014 Plan, 400,000 shares have been approved for grant.

 

As of September 30, 2018, the Company had issued 91,029 restricted and unrestricted shares on a cumulative basis under the plan pursuant to compensatory arrangements with employees, board members and outside consultants. No employee stock options have been issued or are outstanding. The Company issued 15,000 restricted stock units to employees in 2016 and none since that date. Approximately 293,971 shares remain available for grant under the plan.

 

The Company also has issued warrants to investors in connection with financing transactions. Fair value of any warrant issuances is valued utilizing the Black-Scholes model. The model includes subjective input assumptions that can materially affect the fair value estimates. The expected stock price volatility for the Company’s warrants was determined by the average of the historical volatilities for the Company’s common stock.

 

A summary of the warrant activity is presented below:

 

    Number of Warrants     Weighted
Average
Exercise Price
    Weighted
Average
Remaining Life
 
Outstanding January 1, 2018     2,362,615     $ 16.34       6.2  
Granted     403,214       4.50          
Exercised     (100,000 )     3.50          
Forfeited     (94,000 )     48.40          
Outstanding September 30, 2018     2,571,829     $ 13.81       5.7  
                         
Exercisable September 30, 2018     2,571,829     $ 13.81       5.7  

 

Exercise Price   Outstanding Number of Warrants     Weighted Average Remaining Life in Years     Exercisable Number of Warrants  
> $40.00     400,518       0.3       400,518  
$30.00-$39.99     39,990       1.2       39,990  
$20.00-$29.99     77,950       1.3       77,950  
$10.00-$19.99     50,300       2.7       50,300  
$0.00-$9.99     2,003,071       7.1       2,003,071  
      2,571,829       5.7       2,571,829  

 

The Company accepted subscriptions to purchase 403,214 shares of common stock at a purchase price of $3.50 per Share, for a total gross purchase price of approximately $1,411,249 pursuant to a Securities Purchase Agreement dated May 3, 2018 with institutional and accredited investors in a registered direct offering.

 

The offering was made pursuant to a prospectus supplement filed with the Securities and Exchange Commission on March 8, 2018 and an accompanying prospectus dated October 16, 2017, pursuant to the Company’s shelf registration statement on Form S-3 that was filed with the Securities and Exchange Commission on April 27, 2015, amended on June 3, 2015 and became effective on June 9, 2015.

 

The Company also agreed to issue unregistered 5 ½ year warrants to purchase up to 403,214 shares of common stock to the investors in a concurrent private placement at an exercise price of $4.50 per share. The Company has agreed to register the resale of the common shares underlying the warrants, which has been completed. The warrants are exercisable for cash in full commencing six months after the issuance date. The warrants qualified for equity accounting.

 

Larry Spitcaufsky, a director of the Company and greater than 5% shareholder, subscribed for 70,000 Shares and received an equal number of Warrants in the transaction. Michael D. Pruitt, the company’s chairman and Chief Executive Officer also participated in the offering.

 

On October 1, 2018, the maturity dates for warrants covering 201,974 shares of common stock with strike prices ranging from $55.00 to $70.00 per share were extended from October 1, 2018 to October 1, 2020.

 

Oak Ridge Financial Services Group, Inc., a registered broker-dealer acted as placement agent for the offering and received, as compensation, 7% of gross proceeds of the amounts subscribed by institutional investors introduced by Oak Ridge, for an aggregate commission of $36,767 and legal expenses in an amount less than $2,500.